Subscribe
Charlotte Peach of Taylor Wessing
27 May 2025NewsEuropeCharlotte Peach

‘Keep calm and carry on’: UK+ regime stays post-Brexit

With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UK court clears the way for Amgen and Samsung to launch biosimilars
22 May 2025   AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent.
Americas
INTA confirms London as host city for Annual Meeting 2026
20 May 2025   Trademark association confirms UK host city at opening ceremony after news accidentally shared on social media the day before | New mission statement and four-year plan embraces diversity and inclusion | ‘We are, as an organisation, a citizen of the world’ says CEO.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Europe
UK court clears the way for Amgen and Samsung to launch biosimilars
22 May 2025   AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent.
Americas
INTA confirms London as host city for Annual Meeting 2026
20 May 2025   Trademark association confirms UK host city at opening ceremony after news accidentally shared on social media the day before | New mission statement and four-year plan embraces diversity and inclusion | ‘We are, as an organisation, a citizen of the world’ says CEO.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.

More on this story

Europe
UK court clears the way for Amgen and Samsung to launch biosimilars
22 May 2025   AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent.
Americas
INTA confirms London as host city for Annual Meeting 2026
20 May 2025   Trademark association confirms UK host city at opening ceremony after news accidentally shared on social media the day before | New mission statement and four-year plan embraces diversity and inclusion | ‘We are, as an organisation, a citizen of the world’ says CEO.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.

More features

Fed Circ refuses to stay Novartis feud with MSN over Entresto
Moderna entities must face infringement suits, UPC rules
Baker McKenzie adds London partner with ‘enviable’ expertise
As AI shakes up pharma and biotech, can patent law keep up?
UK court clears the way for Amgen and Samsung to launch biosimilars
SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute
‘It’s going to be very different’: INTA CEO shares London meeting plans
'Scrap the billable hour': LSIPR joins INTA panel on gender diversity